product datasheets, catalogs, app notes

31. Sterility Testing Of Products With Antimicrobial Properties 6/4/2024

    Drugs formulated with antibiotics, preservatives, or other chemicals may inhibit microbial viability and growth. Learn more about three golden rules to be effective against antimicrobial effects.

32. Sterility Testing Of Products To Be Diluted In Isopropyl Myristate 6/4/2024

    Discover one possible test set-up to dilute a product in isopropyl myristate, filter it, and rinse the membrane to eliminate residues that may inhibit microbial growth.

33. Overcoming The Solubility Challenges Of Antibody-Drug Conjugates 6/3/2024

    Discover a chito-oligosaccharide that significantly improves the solubility of antibody-drug conjugates (ADCs) when included in the linker-payload construct.

34. Simplifying CHO Cell Line Genetic Stability Testing 4/11/2024

    Here, we describe the use of whole genome sequencing to perform a comprehensive assessment of genetic stability in clonally derived CHO cell banks using the Aptegra™ CHO genetic stability assay.

35. AAV Process Intensification Using High Salt Lysis And Salt Tolerant Endonuclease 3/25/2024

    In the production of adeno-associated virus (AAV) vectors, cell lysis involves challenges addressed through high salt concentrations and a salt-tolerant endonuclease, enhancing titer and infectivity.

36. Novel Enzyme For Nucleic Acid Removal At High Salt Concentrations 3/25/2024

    Learn about a best-in-class solution designed for efficient nucleic acid removal at high salt concentrations.

37. Characterization Of Host Cell Proteins By Liquid Chromatography - Mass Spectrometry 2/26/2024

    Explore an established liquid chromatography – tandem mass spectrometry (LC-MS/MS) method for characterization of residual HCPs in monoclonal antibody (mAb) products.

38. Scalability And Performance Of Mobius® iFlex Bioreactors 1/19/2024

    Utilizing single-use bioreactors in intensified fed-batch and perfusion processes can help manufacturers produce a high-quality drug supply while reducing facility footprint and production costs.

39. Viscosity-Reducing Excipients For Protein Formulation 1/2/2024

    Explore the viscosity-reducing abilities of excipients and excipient combinations, the impact of protein viscosity on injection force, and much more.

40. Viscosity Reducing Excipients For Filtration Process Improvement 1/2/2024

    We demonstrate two filtration methods evaluating the effect of the excipients in the Viscosity Reduction Platform on ultrafiltration processes used to produce a highly concentrated mAb formulation.